Gene regulator profiling in live cells for drug development
Talus Bio is a dynamic biotechnology research company dedicated to advancing drug development through innovative approaches. Focused on gene regulator profiling in live cells, Talus Bio is creating novel solutions for oncology and other critical areas.
Located in Seattle, WA, Talus Bio is committed to building a data-enabled drug development platform that measures a drug’s ability to disrupt a gene regulator within its natural cellular environment. With a focus on small-molecule drug development, Talus Bio's platform simultaneously measures activity for approximately 1,000 gene regulators, providing comprehensive insights into in-cell drug activity and specificity. The company's primary address is 550 17th Ave, Suite 550, Seattle, WA 98122, US.
Talus Bio combines innovative cell processing with high-sensitivity quantitative proteomics and advanced downstream analytics to drive its mission. The company is dedicated to developing internal programs against previously undruggable gene regulators in cancers with poor standards of care and partnering with pharma, biotech, and academic labs to advance their pipeline of gene regulator drugs. We invite the management of Talus Bio to create a customized and exclusive company showcase and product listing on our platform to further enhance their commercial presence.
Other organizations in the same industry
This company is also known as